Markus Ketteler

Medizinische Klinik II, Universitaetsklinikum Aachen, Germany

Markus Ketteler, MD,

Academic positions:
- Consultant Nephrologist at the Department of Nephrology and Clinical Immunology, University Hospital of the RWTH Aachen, Germany
- Chief of the Haemodialysis and the Renal Transplantation Unit
- Assistant Professor at the Department of Nephrology and Clinical Immunology, University Hospital Aachen

All industry positions (in last five years):
None declared

Research interests:
His current research focus is aimed at the understanding of pathomechanisms involved in extra-osseous calcifications and cardiovascular disease in patients with chronic kidney disease (CKD). His research group identified the deficiency of fetuin-A, a circulating calcification inhibitor, as a uraemia- and inflammation-related risk predictor of cardiovascular and all-cause mortality in patients on dialysis.

Any other information:

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Nephrology > Mineral Metabolism & the Kidney (since 14 November 2005)

Links

http://www.ukaachen.de/go/show?NAVDV=0&ID=1026032&DV=0&NAVID=1172712&COMP=person

All recent recommendations

• 3.0
  Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.
  Recommended by Markus Ketteler
  
• 4.9
  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
  Recommended by Peter Stenvinkel, Markus Ketteler with Georg Schlieper, Angela Yee-Moon Wang
  
• 8.8
  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
  Recommended by Kamyar Kalantar-Zadeh, Jurg Schifferli with Michael Mayr, Kenneth White with Emily G Farrow, Bradley Dixon, Csaba Kovesdy, Alan Yu with Jeanie Park, David Salant with Laurence H Beck Jr, Markus Ketteler
  
• 3.0
  Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.
  Recommended by Markus Ketteler
  
• 9.6
  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.
  Recommended by Thomas Schwarz, Markus Ketteler
  
• 3.0
  Denosumab in postmenopausal women with low bone mineral density.
  Recommended by Markus Ketteler